|
Super, Zulassung in Deutschland !!!!!! Encysive Pharmaceuticals Announces Launch of Thelin in Germany Monday December 18, 2:30 am ET First Selective, Once-Daily Oral Endothelin A Receptor Antagonist Now Commercially Available for Pulmonary Arterial Hypertension Patients HOUSTON, Dec. 18, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (NASDAQ:ENCY - News) today announced that THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets are now commercially available in Germany for the treatment of pulmonary arterial hypertension (PAH). The Company received European Union marketing authorization for THELIN from the European Commission in August 2006. THELIN is the first selective endothelin A receptor antagonist and the first once-daily oral treatment available for patients with PAH. |
|
| aus der Diskussion: | 42% Plus Ency und die Thelin (TM) Story |
| Autor (Datum des Eintrages): | kaktus10 (18.12.06 10:04:02) |
| Beitrag: | 9 von 12 (ID:26270097) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |